Company / Book Value per Share
Apellis Pharmaceuticals, Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$2.973
FY2025
5-year range
$1.742 / $2.973
FY2021-FY2025
Trend
+55.5%
vs FY2024
Sector context
#134 of 209
Health Care
What the data says
At $2.973, Apellis Pharmaceuticals, Inc.'s book value per share ranks #134 of 209 in the Health Care sector. Book Value per Share has increased for 3 consecutive years, from $1.742 in FY2022 to $2.973 in FY2025.
Based on SEC 10-K filings.
$2.973 in FY2025 with a 5-year CAGR of -1.5%.
Improved from $1.756 to $2.973 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +19.5%
- 5-Year CAGR
- -1.5%
- 10-Year CAGR
- -
Sector benchmark
#134 of 209 in Health CareTop 64% of 209This company $2.973 Sector average $189.406
▼
-98.4% below sector average
Key checks
Key Insights
- Apellis Pharmaceuticals, Inc.'s book value per share has grown for 3 consecutive years.
- 5-year CAGR of -1.5%, indicating a declining trend.
- In FY2025, book value per share increased 55.5% year-over-year.
- Ranks #134 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.973 | +55.5% |
| FY2024 | $1.912 | +8.9% |
| FY2023 | $1.756 | +0.8% |
| FY2022 | $1.742 | -33.2% |
| FY2021 | $2.61 | -18.4% |
| FY2020 | $3.199 | +481.6% |
| FY2019 | $0.55 | -81.4% |
| FY2018 | $2.959 | -72.4% |
| FY2017 | $10.738 | +280.3% |
| FY2016 | $2.823 | -53.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026